← Leaderboards
Eleanor A Blakely
University Of Calif-Lawrenc Berkeley Lab
$845,139
Attributed
$4,225,693
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2009–16$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,223,170 · 2
By mechanism
RC2$4,225,693 · 1
P20$997,477 · 1
Top collaborators
- Rebecca J Abergel2 shared
- Polly Yee Chang2 shared
- Kenneth N Raymond2 shared
- Mack Roach2 shared
- Reinhard W. Schulte2 shared
- David K Shuh2 shared
Most similar at University Of Calif-Lawrenc Berkeley Lab
Same institution · by research overlap
- Rebecca J Abergel$2,229,966
- Polly Yee Chang$16,021,910
- David K Shuh$845,139
- Daojing Wang$14,771,713
Others in their field
Top investigators on “Research And Development”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,354,865,443
- Leonard Freedman · Leidos Biomedical Research, Inc.$942,960,687
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$551,287,414
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
Research And DevelopmentCollaborationsInternationalToxic EffectIonsDesignDoseInterestProtocols DocumentationResearch InfrastructureRadiationLaboratoriesFutureEffectivenessBiologyBiological SystemsAffinityBiological ModelsBiological AvailabilityAdultActinoid Series ElementsCarbonCarbon IonCanis Familiaris
Grant awards (4)
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer$495,990
P20 · FY2016 · CA
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer$501,487
P20 · FY2015 · CA
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,140,116
RC2 · FY2010 · AI
Biomimetic Actinide Decorporation: Characterization and Preclinical Development$2,085,577
RC2 · FY2009 · AI